89 related articles for article (PubMed ID: 25222531)
1. Testing for sexually transmitted infections at intrauterine device insertion: an evidence-based approach.
Sufrin CB; Averbach SH
Clin Obstet Gynecol; 2014 Dec; 57(4):682-93. PubMed ID: 25222531
[TBL] [Abstract][Full Text] [Related]
2. Neisseria gonorrhea and Chlamydia trachomatis screening at intrauterine device insertion and pelvic inflammatory disease.
Sufrin CB; Postlethwaite D; Armstrong MA; Merchant M; Wendt JM; Steinauer JE
Obstet Gynecol; 2012 Dec; 120(6):1314-21. PubMed ID: 23168755
[TBL] [Abstract][Full Text] [Related]
3. A prospective assessment of pelvic infection risk following same-day sexually transmitted infection testing and levonorgestrel intrauterine system placement.
Turok DK; Eisenberg DL; Teal SB; Keder LM; Creinin MD
Am J Obstet Gynecol; 2016 Nov; 215(5):599.e1-599.e6. PubMed ID: 27180886
[TBL] [Abstract][Full Text] [Related]
4. Best practices to minimize risk of infection with intrauterine device insertion.
Caddy S; Yudin MH; Hakim J; Money DM; ;
J Obstet Gynaecol Can; 2014 Mar; 36(3):266-274. PubMed ID: 24612897
[TBL] [Abstract][Full Text] [Related]
5. Intrauterine Devices in the Context of Gonococcal Infection, Chlamydial Infection, and Pelvic Inflammatory Disease: Not Mutually Exclusive.
Esposito CP
J Midwifery Womens Health; 2020 Jul; 65(4):562-566. PubMed ID: 32592523
[TBL] [Abstract][Full Text] [Related]
6. Acute pelvic inflammatory disease.
Eschenbach DA
Urol Clin North Am; 1984 Feb; 11(1):65-81. PubMed ID: 6369707
[TBL] [Abstract][Full Text] [Related]
7. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
8. Screening for Chlamydia and Gonorrhea: US Preventive Services Task Force Recommendation Statement.
; Davidson KW; Barry MJ; Mangione CM; Cabana M; Caughey AB; Davis EM; Donahue KE; Doubeni CA; Krist AH; Kubik M; Li L; Ogedegbe G; Pbert L; Silverstein M; Simon MA; Stevermer J; Tseng CW; Wong JB
JAMA; 2021 Sep; 326(10):949-956. PubMed ID: 34519796
[TBL] [Abstract][Full Text] [Related]
9. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device.
Shelton JD
Lancet; 2001 Feb; 357(9254):443. PubMed ID: 11273068
[TBL] [Abstract][Full Text] [Related]
10. Sexually transmitted diseases and Chlamydia trachomatis in women consulting for contraception.
Avonts D; Sercu M; Heyerick P; Vandermeeren I; Piot P
J R Coll Gen Pract; 1989 Oct; 39(327):418-20. PubMed ID: 2560023
[TBL] [Abstract][Full Text] [Related]
11. Over-screening for chlamydia and gonorrhea among urban women age ≥25 years.
Jackson JA; McNair TS; Coleman JS
Am J Obstet Gynecol; 2015 Jan; 212(1):40.e1-6. PubMed ID: 24983680
[TBL] [Abstract][Full Text] [Related]
12. Association between enhanced screening for Chlamydia trachomatis and Neisseria gonorrhoeae and reductions in sequelae among women.
Anschuetz GL; Asbel L; Spain CV; Salmon M; Lewis F; Newbern EC; Goldberg M; Johnson CC
J Adolesc Health; 2012 Jul; 51(1):80-5. PubMed ID: 22727081
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of Neisseria gonorrhoea and Chlamydia trachomatis in intra-uterine contraceptive acceptors in Kenya.
Sinei SK; M'riara G; Schulz KF; Njage PN; Lamptey PR; Bhullar VB; Mati JK; Rosenthal SM
J Obstet Gynaecol East Cent Africa; 1988; 7(2):71-3. PubMed ID: 12342410
[TBL] [Abstract][Full Text] [Related]
14. The risk of inadvertent intrauterine device insertion in women carriers of endocervical Chlamydia trachomatis.
Faúndes A; Telles E; Cristofoletti ML; Faúndes D; Castro S; Hardy E
Contraception; 1998 Aug; 58(2):105-9. PubMed ID: 9773265
[TBL] [Abstract][Full Text] [Related]
15. Commentary.
Lundberg S
Ann Emerg Med; 2017 Jul; 70(1):30-31. PubMed ID: 28645411
[No Abstract] [Full Text] [Related]
16. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics.
Mayaud P; Grosskurth H; Changalucha J; Todd J; West B; Gabone R; Senkoro K; Rusizoka M; Laga M; Hayes R
Bull World Health Organ; 1995; 73(5):621-30. PubMed ID: 8846488
[TBL] [Abstract][Full Text] [Related]
17. [Contraception and pelvic infection in women].
Keith L; Berger GS; Brown ER
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):49-58. PubMed ID: 12341241
[TBL] [Abstract][Full Text] [Related]
18. Complications of use of intrauterine devices among HIV-1-infected women.
Sinei SK; Morrison CS; Sekadde-Kigondu C; Allen M; Kokonya D
Lancet; 1998 Apr; 351(9111):1238-41. PubMed ID: 9643743
[TBL] [Abstract][Full Text] [Related]
19. Screening of oropharynx and anorectum increases prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in female STD clinic visitors.
Peters RP; Nijsten N; Mutsaers J; Jansen CL; Morré SA; van Leeuwen AP
Sex Transm Dis; 2011 Sep; 38(9):783-7. PubMed ID: 21844729
[TBL] [Abstract][Full Text] [Related]
20. Preventing infective sequelae of abortion.
Penney GC
Hum Reprod; 1997 Nov; 12(11 Suppl):107-12. PubMed ID: 9433966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
